Pfizer NYSE: PFE has filed 13-F forms with the SEC as an investor. Pfizer is itself a publicly traded company. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. For more information on Pfizer stock, visit the Pfizer stock profile here.
Investment Activity
- Pfizer has $500.84 million in total holdings as of March 31, 2025.
- Pfizer owns shares of 21 different stocks, but just 4 companies or ETFs make up 80% of its holdings.
- Approximately 0.04% of the portfolio was purchased this quarter.
- About 378.81% of the portfolio was sold this quarter.
- This quarter, Pfizer has purchased 23 new stocks and bought additional shares in 1 stock.
- Pfizer sold shares of 0 stocks and completely divested from 2 stocks this quarter.
Largest Holdings
- TOURMALINE BIO INC
- $19,350,375
Largest Purchases this Quarter
- NextCure
- 433,213 shares (about $208.07K)
